The BIA has submitted a letter to Guy Opperman MP as part of the Department for Work and Pensions' (DWP) consultation on Broadening the investment opportunities of defined contribution pension schemes.
In this article, Giuseppe Amoroso, R&D Tax Advisor for biotech companies, explores the critical role of R&D tax compliance in the biotechnology sector.
Prostate cancer is the most common cancer among men, with over 136 new diagnoses in the UK each day. Stratosvir, a leading company in viral immunotherapy, is changing the landscape of treatment.
As Donald Trump returns to the White House, the biotech industry is assessing what his presidency means for investment and innovation. With the UK’s life sciences sector gaining strength, could this be the moment to turn uncertainty into opportunity?
The UK biotech sector raised £3.5 billion in 2024, a 94% increase from the previous year, marking the highest level since 2021. Investment was concentrated in a few companies, with US investors leading the way.
